Actively Recruiting
Intensive Speech Motor Chaining Treatment for Residual Speech Sound Disorders
Led by Syracuse University · Updated on 2026-01-13
84
Participants Needed
1
Research Sites
226 weeks
Total Duration
On this page
Sponsors
S
Syracuse University
Lead Sponsor
N
National Institutes of Health (NIH)
Collaborating Sponsor
AI-Summary
What this Trial Is About
The goal of this randomized-controlled trial is to compare distributed treatment schedules and intensive treatment schedules in 84 school-age children with residual speech sound disorders. The main question it aims to answer is: * How does intensive and distributed treatment affect speech sound learning in residual speech sound disorder? Some participants will be treated with a traditional Distributed schedule of 2 sessions per weeks for 8 weeks (16 hours total), whereas others will be treated with an Intensive schedule and will complete 16 hours of treatment in 4 weeks.
CONDITIONS
Official Title
Intensive Speech Motor Chaining Treatment for Residual Speech Sound Disorders
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Must speak American English as a dominant language.
- Must have began learning English by at least the age of 3 years.
- Must be between 9;0 to 17;11 years of age.
- Must have reported difficulty with /ɹ/ and/or /s/ production.
- Must pass pure tone hearing screening at 25 dB at 1000, 2000, and 4000 Hz.
- Must receive a scaled score of at least 5 on the Listening Comprehension and Story Retelling subtests of the Test of Integrated Language and Literacy Skills (TILLS).
- Must receive a percentile score of 5 or below on the Goldman-Fristoe Test of Articulation-3 (GFTA-3) Sounds in Words subtest.
- Must have 1 scorable response with 5+ consecutive correct /pataka/ with > 3.4 syllables per second in the MRR-Tri task of the Maximum Performance Tasks OR must demonstrate no childhood apraxia of speech (CAS-only) features in BOTH articulatory and rate/prosody domains of the ProCAD.
- Must score <40% accurate on /ɹ/ and/or /s/ probes assessing these sounds at the word level.
- Must express a desire to modify their speech.
You will not qualify if you...
- Must have no known history of autism spectrum disorder, Down Syndrome, cerebral palsy, intellectual disability, permanent hearing loss, or brain injury.
- Must not have current cleft palate or voice disorder.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Syracuse University
Syracuse, New York, United States, 13244
Actively Recruiting
Research Team
J
Jonathan Preston, PhD
CONTACT
N
Nina Benway, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here